The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series

Published:2023-08 Issue: Volume:Volume 16 Page:2357-2363
ISSN:1178-7015
Container-title:Clinical, Cosmetic and Investigational Dermatology
language:en
Short-container-title:CCID

Author:

Chen Jiaoquan,Yu Nanji,Wu Weihong,Ou Shanshan,Chen Quan,Zhu Huilan

Publisher

Informa UK Limited

Subject

Dermatology

Reference20 articles.

1. Comparison of Demographic and Photobiological Features of Chronic Actinic Dermatitis in Patients With Lighter vs Darker Skin Types

2. Diagnosis and Pharmacological Treatment of Chronic Actinic Dermatitis in the Elderly

3. Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature;Acta Dermato-Venereologica;2024-08-23

2. Dupilumab in chronic actinic dermatitis: a retrospective case series;British Journal of Dermatology;2024-04-24

3. Dupilumab for chronic actinic dermatitis: A case series and review of the literature;Australasian Journal of Dermatology;2024-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP